{"mainPropery":{"diseaseId":3263,"diseaseName":"Dihydrolipoamide dehydrogenase deficiency","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/3263/dihydrolipoamide-dehydrogenase-deficiency","synonyms":["Pyruvate dehydrogenase E3 deficiency","DLD deficiency","E3-deficient maple syrup urine disease","E3 deficiency","Maple syrup urine disease, type III"],"synonyms-with-source":[{"name":"Pyruvate dehydrogenase E3 deficiency","source":"Orphanet"},{"name":"DLD deficiency","source":"Orphanet"},{"name":"E3-deficient maple syrup urine disease","source":"Orphanet"},{"name":"E3 deficiency","source":"OMIM"},{"name":"Maple syrup urine disease, type III","source":"OMIM"}],"identifiers":[{"identifierType":"OMIM","identifierId":"246900"},{"identifierType":"ORPHANET","identifierId":"2394"},{"identifierType":"UMLS","identifierId":"C0268193"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/246900' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=%22Dihydrolipoamide+dehydrogenase+deficiency%22+OR+%22Dihydrolipoamide+dehydrogenase+(DLD)+deficiency%22' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Dihydrolipoamide dehydrogenase deficiency. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/dihydrolipoamide-dehydrogenase-deficiency' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Dihydrolipoamide dehydrogenase deficiency. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2394' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/books/NBK220444/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:246900' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":9319,"questionText":"What is dihydrolipoamide dehydrogenase deficiency?","answerText":"<strong>Dihydrolipoamide dehydrogenase (DLD) deficiency</strong> is a very rare condition that can vary in age of onset, symptoms and severity. The condition may be characterized by early-onset <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000391.htm\" target=\"_blank\">lactic acidosis</a> and delayed development (most commonly); later-onset neurological dysfunction; or adult-onset isolated <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000205.htm\" target=\"_blank\">liver disease</a>. Signs and symptoms may include lactic acidosis shortly after birth; <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003298.htm\" target=\"_blank\">hypotonia</a> and lethargy in infancy; feeding difficulties; seizures; and various other health issues. Liver problems can range from <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/003275.htm\" target=\"_blank\">hepatomegaly</a> to life-threatening liver failure. Symptoms often occur in episodes that may be triggered by illness or other stresses on the body. Many affected infants do not survive the first few years of life; those who survive through early childhood often have growth delay and intellectual disability. Some with onset later in childhood may have neurological dysfunction with normal cognitive development. DLD deficiency is caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a> in the <em><a href=\"http://ghr.nlm.nih.gov/gene/DLD\" target=\"_blank\">DLD</a></em> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner.[9543][9544][9545]","dateModified":"2015-08-26T10:23:00"},"basicQuestions":[{"questionId":9320,"questionText":"What are the signs and symptoms of dihydrolipoamide dehydrogenase deficiency?","answerText":"The signs and symptoms of dihydrolipoamide dehydrogenase (DLD) deficiency can vary widely among affected people. Early-onset DLD deficiency typically appears in early infancy with decreased muscle tone (hypotonia), lethargy, and <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000391.htm\" target=\"_blank\">lactic acidosis</a>. Lactic acidosis can cause nausea, vomiting, severe breathing problems, and an abnormal heartbeat. Symptoms typically occur in episodes that may be triggered by illness, injury, or other stresses on the body. Affected infants often do not survive their initial episode or may die within the first few years of life during a recurrent episode. Children who live beyond the first two to three years often have growth delays and neurological problems such as intellectual disability, <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/003297.htm\" target=\"_blank\">spasticity</a>, <a href=\"http://www.merriam-webster.com/medlineplus/ataxia\" target=\"_blank\">ataxia</a>, and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003200.htm\" target=\"_blank\">seizures</a>. However,&nbsp;normal intellect has been reported in a few people with the early-onset form of DLD deficiency.[9543][9544][9545]<br />\r\n<br />\r\nIsolated liver involvement, which can range from hepatomegaly (enlarged liver) to life-threatening liver failure, can also occur in the newborn period, or as late as the 3rd decade of life. A few people with DLD deficiency have become affected later in childhood with ataxia and <a href=\"https://www.nlm.nih.gov/medlineplus/dystonia.html\" target=\"_blank\">dystonia</a>, with normal cognitive development. Rarely, affected people have muscle weakness (particularly during exercise) or a weakened heart muscle (cardiomyopathy).[9543][9544][9545]","dateModified":"2015-08-26T10:24:00","resourceClassificationName":"Symptoms","references":[{"referenceId":9543,"authors":"Shane C Quinonez and Jess G Thoene","articleTitle":"Dihydrolipoamide Dehydrogenase Deficiency","bookWebsiteJournalTitle":"GeneReviews","date":"July 17, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK220444/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9544,"authors":"","articleTitle":"Dihydrolipoamide dehydrogenase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference","date":"September, 2014","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/dihydrolipoamide-dehydrogenase-deficiency","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9545,"authors":"Brown G","articleTitle":"Pyruvate dehydrogenase E3 deficiency","bookWebsiteJournalTitle":"Orphanet","date":"April, 2012","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2394","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9321,"questionText":"What causes dihydrolipoamide dehydrogenase deficiency?<br />","answerText":"Dihydrolipoamide dehydrogenase (DLD) deficiency is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <em><a href=\"http://ghr.nlm.nih.gov/gene/DLD\" target=\"_blank\">DLD</a></em> gene. This gene gives the body instructions to make an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002353.htm\" target=\"_blank\">enzyme</a> called dihydrolipoamide dehydrogenase (DLD). DLD is one part of 3 different groups of enzymes that work together (enzyme complexes). These enzyme complexes are involved in breaking down <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002222.htm\" target=\"_blank\">amino acids</a> commonly found in protein-rich foods, and in other reactions that help to convert energy from food into a form that our cells can use.[9544]<br />\r\n<br />\r\nMutations in the <em>DLD</em> gene impair the function of DLD, preventing the 3 enzyme complexes from functioning properly. This causes a build-up of molecules that are normally broken down, which in turn leads to tissue damage, lactic acidosis and other chemical imbalances. The brain is especially sensitive to the buildup of molecules and lack of cellular energy, which is why there are neurological problems associated with DLD deficiency.[9544]","dateModified":"2015-08-26T10:24:00","resourceClassificationName":"Cause","references":[{"referenceId":9544,"authors":"","articleTitle":"Dihydrolipoamide dehydrogenase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference","date":"September, 2014","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/dihydrolipoamide-dehydrogenase-deficiency","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9322,"questionText":"How is dihydrolipoamide dehydrogenase deficiency inherited?","answerText":"Dihydrolipoamide dehydrogenase (DLD) deficiency is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner.[9544] This means that a person must have a <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a> in both copies of the responsible <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a> in each cell to be affected. The parents of an affected person usually each carry one mutated copy of the gene and are referred to as <a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carriers</a>. Carriers typically do not have any signs or symptoms of the condition. When two carriers of an autosomal recessive condition have children, each child has a 25% (1 in 4) risk to be affected, a 50% (1 in 2) risk to be a carrier like each of the parents, and a 25% to be unaffected <em>and</em> not be a carrier.","dateModified":"2015-08-27T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":9544,"authors":"","articleTitle":"Dihydrolipoamide dehydrogenase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference","date":"September, 2014","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/dihydrolipoamide-dehydrogenase-deficiency","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9323,"questionText":"How might dihydrolipoamide dehydrogenase deficiency be treated?","answerText":"There are currently no consensus recommendations for the management of dihydrolipoamide dehydrogenase (DLD) deficiency. Management can be hard because various metabolic pathways are affected and 3 enzyme complexes are involved. Deficiencies in enzyme pathways vary depending on the specific mutation(s) each affected person has.<br />\r\n<br />\r\nUnfortunately, the treatments that have been attempted in children with the early-onset neurologic form do not appear to significantly alter the course of the disease. Even with treatment, children often do not survive infancy or have varying degrees of chronic neurologic impairment if they survive the initial episode. Depending on individual enzyme complex deficiencies, treatment may involve certain dietary restrictions or certain diets; use of medical foods; and/or supplementation of specific amino acids or other substances.<br />\r\n<br />\r\nThere is limited data for the chronic management of people with the primarily hepatic (liver-related) form of the disease. Management typically involves supportive therapy during times of acute liver injury or failure, and may include nutritional support; IV glucose for hypoglycemia; correction of metabolic acidosis; correction of coagulopathy; and avoidance of liver-toxic medications.[9543]<br />\r\n<br />\r\n<a href=\"http://www.ncbi.nlm.nih.gov/books/NBK220444/#dld-def.Management\" target=\"_blank\">More detailed information about the management of DLD deficiency can be viewed on the GeneReviews Web site</a>. GeneReviews is intended for use by genetics professionals. Those not familiar with the principles discussed on the GeneReviews Web site are encouraged to speak with a genetics professional or other healthcare provider regarding information of interest.","dateModified":"2015-08-27T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":9543,"authors":"Shane C Quinonez and Jess G Thoene","articleTitle":"Dihydrolipoamide Dehydrogenase Deficiency","bookWebsiteJournalTitle":"GeneReviews","date":"July 17, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK220444/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9324,"questionText":"What is the long-term outlook for people with dihydrolipoamide dehydrogenase deficiency?","answerText":"The long-term outlook (prognosis) for people with dihydrolipoamide dehydrogenase (DLD) deficiency depends on the specific symptoms and severity in each person. Children diagnosed in the newborn period often do not survive their first episode or die within the first few years of life.[9544] However, multiple people have been reported surviving into their second and third decade of life.[9549] Those who survive past early childhood often have delayed growth and various neurological problems including intellectual disability, spasticity, ataxia, and seizures.[9544]<br />\r\n<br />\r\nThose who become symptomatic after the neonatal period typically have milder signs and symptoms, with a significantly lower mortality rate. However, given the limited amount of information available in the medical literature, the degree of morbidity that surviving people experience is difficult to determine.[9549] The frequency of acute episodes reportedly decreases with age in most people with DLD deficiency.[9543]","dateModified":"2015-08-27T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":9543,"authors":"Shane C Quinonez and Jess G Thoene","articleTitle":"Dihydrolipoamide Dehydrogenase Deficiency","bookWebsiteJournalTitle":"GeneReviews","date":"July 17, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK220444/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9544,"authors":"","articleTitle":"Dihydrolipoamide dehydrogenase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference","date":"September, 2014","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/dihydrolipoamide-dehydrogenase-deficiency","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9549,"authors":"Shane C. Quinonez, Steven M. Leber, Donna M. Martin, Jess G. Thoene, and Jirair K. Bedoyan","articleTitle":"Leigh syndrome in a girl with a novel DLD mutation causing E3 deficiency","bookWebsiteJournalTitle":"Pediatr Neurol","date":"January, 2013","volume":"48(1)","pages":"67-72","url":"","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12679,"relatedDiseaseName":"Lipoic acid biosynthesis defects","relation":"Parent","isRare":true,"hasGardPage":true},{"relatedDiseaseId":7513,"relatedDiseaseName":"Pyruvate dehydrogenase complex deficiency","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":9384,"phenoTypeName":"Generalized hypotonia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13834,"phenoTypeName":"Increased serum lactate","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14576,"phenoTypeName":"Lactic acidosis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9043,"phenoTypeName":"Neurodevelopmental delay","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13400,"phenoTypeName":"Vomiting","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4319,"phenoTypeName":"Elevated hepatic transaminase","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15633,"phenoTypeName":"Elevated plasma branched chain amino acids","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13239,"phenoTypeName":"Feeding difficulties","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5230,"phenoTypeName":"Hepatic encephalopathy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11808,"phenoTypeName":"Hypercoagulability","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13041,"phenoTypeName":"Hypoglycemia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":12596,"phenoTypeName":"Increased urine alpha-ketoglutarate concentration","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8721,"phenoTypeName":"Lethargy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8711,"phenoTypeName":"Spasticity","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14607,"phenoTypeName":"Abnormal cardiac ventricular function","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6005,"phenoTypeName":"Behavioral abnormality","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4782,"phenoTypeName":"Cardiomyopathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5702,"phenoTypeName":"Decreased liver function","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10926,"phenoTypeName":"Decreased plasma carnitine","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4081,"phenoTypeName":"Failure to thrive","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5685,"phenoTypeName":"Hepatic failure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13089,"phenoTypeName":"Hyperammonemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7851,"phenoTypeName":"Hyperisoleucinemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9844,"phenoTypeName":"Microcephaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5588,"phenoTypeName":"Muscle spasm","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10515,"phenoTypeName":"Reduced visual acuity","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":9421,"phenoTypeName":"Dystonia","percentRanges":"-"},{"phenoTypeId":9387,"phenoTypeName":"Encephalopathy","percentRanges":"-"},{"phenoTypeId":8970,"phenoTypeName":"Hypertrophic cardiomyopathy","percentRanges":"-"},{"phenoTypeId":13040,"phenoTypeName":"Metabolic acidosis","percentRanges":"-"},{"phenoTypeId":7381,"phenoTypeName":"Variable expressivity","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Dihydrolipoamide_dehydrogenase_deficiency"}